Immunic Inc (IMUX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,027 | -4,313 | -11,542 | -6,730 | -4,933 |
| Depreciation Amortization | 29 | 5 | 15 | 10 | 7 |
| Accounts payable and accrued liabilities | -1,423 | -880 | 1,200 | 195 | 529 |
| Other Working Capital | -4,803 | -1,009 | 1,788 | 427 | 718 |
| Other Operating Activity | 8,920 | 880 | -1,199 | -195 | -529 |
| Operating Cash Flow | $-16,304 | $-5,317 | $-9,738 | $-6,293 | $-4,208 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 1,173 | -7 | -32 | -12 | -7 |
| Net Acquisitions | 8,151 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $9,324 | $-7 | $-32 | $-12 | $-7 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 29,965 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 20,531 | 19,256 | 12,564 | 12,564 |
| Financing Cash Flow | $29,965 | $20,531 | $19,256 | $12,564 | $12,564 |
| Exchange Rate Effect | 64 | -260 | -918 | -743 | -722 |
| Beginning Cash Position | 13,072 | 13,072 | 4,504 | 4,504 | 4,504 |
| End Cash Position | 36,121 | 28,019 | 13,072 | 10,020 | 12,131 |
| Net Cash Flow | $23,049 | $14,947 | $8,568 | $5,516 | $7,627 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,304 | -5,317 | -9,738 | -6,293 | -4,208 |
| Capital Expenditure | -17 | -7 | -32 | -12 | -7 |
| Free Cash Flow | -16,321 | -5,324 | -9,770 | -6,305 | -4,215 |